Dr. Richard Friedberg is an award-winning Senior Executive with 25+ years of worldwide success in medicine, academics, biotechnology, and medical diagnostics. His direct experience in health care delivery, compliance, strategic planning, and risk mitigation includes key leadership positions throughout his executive career in diverse private, public, and academic sectors.

Dr. Friedberg’s private sector experience includes development of analytical tools for biomarker identification and probabilistic outcome prediction. In 2000, he helped start MedMined, one of the
first commercially successful data mining applications in the clinical laboratory to optimize delivery, improve safety, and control expenses. More recent ventures include executive and leadership roles at Bionysis (healthcare data analytics), DecisionQ (applied algorithmic insights), EmpiraMed (patient engagement software for PRO in RWE), TractusMed (cross-platform data aggregation for nation-level databases), and QuantDiagnostics (diagnostic Bayesian belief networks). His consulting corporation advises biotechnology companies, universities, and management consultants on laboratory development, market dynamics, product development, regulatory issues, and reimbursement matters. More recently, he helped create and still leads the Harvard University Clinical Laboratory for COVID-19 PCR testing at major Boston universities.

In the public sector, Dr. Friedberg has been deeply involved with the College of American Pathologists (CAP), the worldwide leader in laboratory quality assurance (20,000 customers, 100  countries) and among the largest professional medical associations worldwide. His 11 years of elected service on the CAP Board of Governors included 4 years as an Officer. As President (’15- ’17),  he led the CAP through significant strategic, operational, and regulatory challenges, including existential threats and a CEO transition. He interacted directly with health care leaders at the highest levels, including the White House, National Academies of Medicine (IOM), and foreign agencies. In 2015, ThePathologist.com naming him to their Top 100 Power List Worldwide. For CAP, Dr. Friedberg has performed more than 50 regulatory inspections in 13 countries and was formally recognized as 2018 Pathologist of the Year.

Dr. Friedberg’s academic experience includes 30+ years of University medical school experience at Massachusetts (Professor, Chair), Tufts (Professor, Deputy Chair), and Alabama (Tenured
Associate Professor). He was Professor and Chair of Pathology for 17 years at Baystate Health, and Medical Director for Baystate Reference Laboratories which grew 10x under his leadership to became one of the largest clinical laboratories in New England. Previously, he was Chief of Pathology & Laboratory Medicine for the Birmingham VA, where he created and led the VISN7 Diagnostic Medicine Service Line covering AL, GA, & SC. He holds degrees in Health Care Management (MS, Harvard), Medicine/Biochemistry (MD/PhD, Duke), and Biology (BS Honors, Stanford). Altogether, Dr Friedberg has contributed significantly to the fields of medical diagnostics, with 280+ publications, 280+ invited presentations (12 keynotes, 31 states, 15 countries), and  120+ media presentations, interviews, and quotations.